M&A Deal Summary |
|
|---|---|
| Date | 2018-04-23 |
| Target | OriGene Technologies |
| Sector | Life Science |
| Buyer(s) | Vcanbio |
| Sellers(s) | Cathay Capital Private Equity |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1992 |
| Sector | Life Science |
| Employees | 2,332 |
| Revenue | 1.6B CNY (2022) |
Vcanbio is a life science and technology innovative enterprise with the core vision of developing "precision medicine" (stock code: 600645). The company focuses on three major sectors: "precision prevention", "precision diagnosis" and "cell therapy". Its main business covers cell testing preparation and storage, research, production and sales of in vitro diagnostic raw materials, in vitro diagnostic reagents and equipment, and scientific research reagents such as biological genes, proteins and antibodies. Vcanbio was founded in 1992 and is based in Tianjin, China.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Add-on Acquisition) | 1 of 1 |
| State (Maryland) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2018) | 1 of 1 |
| Category | Private Equity Firm |
|---|---|
| Founded | 2006 |
| PE ASSETS | 5.0B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Cathay Capital Private Equity SAS is a French Chinese private equity firm focused on acquiring businesses in France, Hong Kong, and China. Cathay looks to help Western companies leverage opportunities in China and help Chinese companies leverage Western best practices and partnerships. The Firm looks to invest in businesses generating €5 to €150 million in revenues. Areas of interest include retail, consumer goods, electrical equipment, medical devices, pharmaceuticals, animal healthcare, translation, food, consumer services, and software. Cathay Capital Private Equity SAS was formed in 2007 and is based in Paris. The firm has additional offices in New York and Shanghai.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 29 |
| Sector (Life Science) | 3 of 5 |
| Type (Add-on Acquisition) | 2 of 7 |
| State (Maryland) | 1 of 1 |
| Country (United States) | 2 of 2 |
| Year (2018) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-03-09 |
Echosens
Paris, France Echosens is a specialized diagnostic company providing non-invasive medical devices and services to support physicians in their diagnostic and monitoring of chronic liver diseases. Echosens was founded in 2001 and is based in Paris, France. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-05-04 |
NeoXam
Paris, France NeoXam is a provider of investment accounting, investment management, and data management software solutions. NeoXam's customer base is made of large and medium asset management firms, investment banks, institutional investors, and securities services providers. NeoXam was founded in 2014 and is based in Paris, France. |
Buy | - |
